Sevinc Sarinc Ulasli1, Muzaffer Sarıaydın2, Ersin Gunay2, Bilal Halici2, Sefa Celik3, Tulay Koyuncu2, Sena Ulu4, Mehmet Unlu2. 1. Faculty of Medicine, Department of Pulmonary Diseases, Afyon Kocatepe University, Afyonkarahisar, Afyon, Turkey. sevincsarinc@gmail.com. 2. Faculty of Medicine, Department of Pulmonary Diseases, Afyon Kocatepe University, Afyonkarahisar, Afyon, Turkey. 3. Faculty of Medicine, Department of Biochemistry, Afyon Kocatepe University, Afyonkarahisar, Afyon, Turkey. 4. Faculty of Medicine, Department of Internal Medicine, Afyon Kocatepe University, Afyonkarahisar, Afyon, Turkey.
Abstract
BACKGROUND: Obstructive sleep apnea syndrome (OSAS) is a highly prevalent chronic systemic disease in the general population with high morbidity and mortality. Nondipping pattern-failure to drop blood pressure levels in nighttime-is also seen in OSAS patients. We aim to investigate dipping and nondipping patterns of OSAS patients and to compare inflammatory markers. MATERIALS AND METHODS: Patients with the confirmed diagnosis of OSAS with polysomnography underwent ambulatory blood pressure monitoring. During monitoring, patients with decreased nighttime mean systolic blood pressures 10 % or more were defined as dippers, and the patients without this amount of decrease were defined as nondippers. Peripheral venous blood samples were collected for the analysis of IL-2, IL-6, IL-8, IL-10, IL-12, and TNF-α. Results were compared with convenient statistical tests. RESULTS: According to monitoring results, 34 of 62 OSAS patients were dipper and 28 of 62 patients were nondipper. Demographic characteristics, OSAS severity, and Apnea Hypopnea Index were similar in both groups. When inflammatory markers were compared between two groups, IL-2 levels were found to be significantly different (p = 0.014). CONCLUSION: In conclusion, nondipping pattern appears to be associated with increased serum IL-2 levels indicating the increased inflammatory response independently from OSAS severity, and this pattern should be evaluated carefully for possible cardiovascular complications.
BACKGROUND:Obstructive sleep apnea syndrome (OSAS) is a highly prevalent chronic systemic disease in the general population with high morbidity and mortality. Nondipping pattern-failure to drop blood pressure levels in nighttime-is also seen in OSAS patients. We aim to investigate dipping and nondipping patterns of OSAS patients and to compare inflammatory markers. MATERIALS AND METHODS:Patients with the confirmed diagnosis of OSAS with polysomnography underwent ambulatory blood pressure monitoring. During monitoring, patients with decreased nighttime mean systolic blood pressures 10 % or more were defined as dippers, and the patients without this amount of decrease were defined as nondippers. Peripheral venous blood samples were collected for the analysis of IL-2, IL-6, IL-8, IL-10, IL-12, and TNF-α. Results were compared with convenient statistical tests. RESULTS: According to monitoring results, 34 of 62 OSAS patients were dipper and 28 of 62 patients were nondipper. Demographic characteristics, OSAS severity, and Apnea Hypopnea Index were similar in both groups. When inflammatory markers were compared between two groups, IL-2 levels were found to be significantly different (p = 0.014). CONCLUSION: In conclusion, nondipping pattern appears to be associated with increased serum IL-2 levels indicating the increased inflammatory response independently from OSAS severity, and this pattern should be evaluated carefully for possible cardiovascular complications.
Authors: Eoin O'Brien; Gianfranco Parati; George Stergiou; Roland Asmar; Laurie Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang Journal: J Hypertens Date: 2013-09 Impact factor: 4.844
Authors: Eoin O'Brien; Roland Asmar; Lawrie Beilin; Yutaka Imai; Giuseppe Mancia; Thomas Mengden; Martin Myers; Paul Padfield; Paolo Palatini; Gianfranco Parati; Thomas Pickering; Josep Redon; Jan Staessen; George Stergiou; Paolo Verdecchia Journal: J Hypertens Date: 2005-04 Impact factor: 4.844
Authors: Kudret Aytemir; Ali Deniz; Bunyamin Yavuz; Ahmet Ugur Demir; Levent Sahiner; Orcun Ciftci; Lale Tokgozoglu; Iknur Can; Altay Sahin; Ali Oto Journal: Respir Med Date: 2006-11-29 Impact factor: 3.415
Authors: Micha T Maeder; Werner Strobel; Michael Christ; John Todd; Joel Estis; Karin Wildi; Gregor Thalmann; Jonas Hilti; Martin Brutsche; Raphael Twerenbold; Hans Rickli; Christian Mueller Journal: Clin Biochem Date: 2014-09-16 Impact factor: 3.281
Authors: Sophie J Crinion; Silke Ryan; Jana Kleinerova; Brian D Kent; Joseph Gallagher; Mark Ledwidge; Kenneth McDonald; Walter T McNicholas Journal: J Clin Sleep Med Date: 2019-07-15 Impact factor: 4.062
Authors: Claudia M Correa; Ronaldo A Gismondi; Ana Rosa Cunha; Mario F Neves; Wille Oigman Journal: Arq Bras Cardiol Date: 2017-09-04 Impact factor: 2.000